Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Barry

Showing results (671-680 of 1,132) with videos related to

Pageof 114
Sort By:
Antimicrobial Agents and Chemotherapy|January 1, 1995
Antifungal susceptibility testing of isolates from a randomized, multicenter trial of fluconazole versus amphotericin B as treatment of nonneutropenic patients with candidemia. NIAID Mycoses Study Group and the Candidemia Study GroupJ H Rex, M A Pfaller, A L Barry, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|December 1, 1990
Prevalence of fluoroquinolone-resistant bacterial isolates in four medical centers during the first quarter of 1990A L Barry, P C Fuchs, M A Pfaller, et al.
Journal of Geriatric Psychiatry and Neurology|July 27, 2000
Age-group differences in treatment outcomes for male veterans with severe schizophrenia: a three-year longitudinal studyJ S Roberts, F C Blow, L A Copeland, et al.
Journal of Clinical Microbiology|August 1, 1992
Proposed interpretive criteria and quality control parameters for testing susceptibility of Neisseria gonorrhoeae to beta-lactam-clavulanate combinationsP C Fuchs, A L Barry, C N Baker, et al.
Journal of Clinical Microbiology|August 1, 1992
Development of revised quality control limits for disk diffusion susceptibility tests of selected cephem antibiotics with Haemophilus influenzae and description of a new control strainJ H Jorgensen, A L Barry, G V Doern, et al.
European Journal of Clinical Microbiology|June 1, 1984
In vitro activity of ticarcillin plus clavulanic acid against bacteria isolated in three centersA L Barry, L W Ayers, T L Gavan, et al.
Preventive Medicine|November 11, 2021
Public support for U.S. social safety net policies throughout the COVID-19 pandemicRachel J Topazian, C Ross Hatton, Colleen L Barry, et al.
The Milbank Quarterly|March 15, 2006
Health plans respond to parity: managing behavioral health care in the Federal Employees Health Benefits ProgramM Susan Ridgely, M Audrey Burnam, Colleen L Barry, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|July 22, 2021
Oral Antibiotics and Risk of New Colorectal Adenomas During Surveillance Follow-upMichael N Passarelli, Leila A Mott, Elizabeth L Barry, et al.
The Journal of Antimicrobial Chemotherapy|April 1, 1986
Activity of temocillin and ticarcillin against consecutively isolated Enterobacteriaceae in four medical centresA L Barry, R N Jones, L W Ayers, et al.
Pageof 114

Showing results (671-680 of 1,132) with videos related to

Sort By:
Pageof 114
Antimicrobial Agents and Chemotherapy|January 1, 1995
Antifungal susceptibility testing of isolates from a randomized, multicenter trial of fluconazole versus amphotericin B as treatment of nonneutropenic patients with candidemia. NIAID Mycoses Study Group and the Candidemia Study GroupJ H Rex, M A Pfaller, A L Barry, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|December 1, 1990
Prevalence of fluoroquinolone-resistant bacterial isolates in four medical centers during the first quarter of 1990A L Barry, P C Fuchs, M A Pfaller, et al.
Journal of Geriatric Psychiatry and Neurology|July 27, 2000
Age-group differences in treatment outcomes for male veterans with severe schizophrenia: a three-year longitudinal studyJ S Roberts, F C Blow, L A Copeland, et al.
Journal of Clinical Microbiology|August 1, 1992
Proposed interpretive criteria and quality control parameters for testing susceptibility of Neisseria gonorrhoeae to beta-lactam-clavulanate combinationsP C Fuchs, A L Barry, C N Baker, et al.
Journal of Clinical Microbiology|August 1, 1992
Development of revised quality control limits for disk diffusion susceptibility tests of selected cephem antibiotics with Haemophilus influenzae and description of a new control strainJ H Jorgensen, A L Barry, G V Doern, et al.
European Journal of Clinical Microbiology|June 1, 1984
In vitro activity of ticarcillin plus clavulanic acid against bacteria isolated in three centersA L Barry, L W Ayers, T L Gavan, et al.
Preventive Medicine|November 11, 2021
Public support for U.S. social safety net policies throughout the COVID-19 pandemicRachel J Topazian, C Ross Hatton, Colleen L Barry, et al.
The Milbank Quarterly|March 15, 2006
Health plans respond to parity: managing behavioral health care in the Federal Employees Health Benefits ProgramM Susan Ridgely, M Audrey Burnam, Colleen L Barry, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|July 22, 2021
Oral Antibiotics and Risk of New Colorectal Adenomas During Surveillance Follow-upMichael N Passarelli, Leila A Mott, Elizabeth L Barry, et al.
The Journal of Antimicrobial Chemotherapy|April 1, 1986
Activity of temocillin and ticarcillin against consecutively isolated Enterobacteriaceae in four medical centresA L Barry, R N Jones, L W Ayers, et al.
Pageof 114